JuLib | Articles & more - {"Langen, K. J."}

Differential neural structures, intrinsic functional connectivity, and episodic memory in subjective cognitive decline and healthy controls

Nellessen, Nils
2021

Neurobiology of aging, 105 (2021) S. 159-173

“...Langen, K. J....”
Get full text Published on 2021-04-28. Available in OpenAccess from 2022-04-28.

3

Current landscape and emerging fields of PET imaging in patients with brain tumors

Werner, J. M.
2020

Molecules, 25 (2020) 6, S. 1471

“...Langen, K. J....”
Get full text OpenAccess OpenAccess

4

Differentiation of treatment-related changes from tumor progression: A direct comparison between dynamic FET PET and ADC values obtained from DWI MRI

Werner, J. M.
2019

“...Langen, K. J....”

5

Combined FET PET/MRI radiomics differentiates radiation injury from brain metastasis recurrence

Lohmann, Philipp
2019

“...Langen, K. J....”

6

FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.

Lohmann, Philipp
2019

“...Langen, K. J....”

7

Treatment monitoring of immunotherapy and targeted therapy using FET PET in patients with melanoma and lung cancer brain metastases: Initial experiences

Galldiks, Norbert
2019

“...Langen, K. J....”

8

Spatial discrepancies between FET PET and conventional MRI in patients with newly diagnosed glioblastoma

Lohmann, Philipp
2019

“...Langen, K. J....”

9

FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.

Lohmann, P.
2019

European journal of nuclear medicine and molecular imaging, 46 (2019) 3, S. 591-602

“...Langen, K. J....”
Restricted OpenAccess Restricted

10

Photopenic defects on O-(2-18F-fluoroethyl)-L-tyrosine PET - clinical relevance in glioma patients.

Galldiks, Norbert
2018

“...Langen, K. J....”

11

Prediction of progression-free survival in patients with malignant glioma using dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET

Bauer, E. K.
2017

“...Langen, K. J....”

12

The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma

Galldiks, N.
2015

Neuro-Oncology, 17 (2015) 9, S. 1293-1300

“...Langen, K.-J....”

13

Diagnosis of Pseudoprogression in Patients with Glioblastoma Using Amino Acid PET

Galldiks, N.
2015

2015

“...Langen, K. J....”

14

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Langen, K. J....”

15

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Langen, K. J....”

16

The usefulness of dynamic O-(2-18F-Fluoroethyl)-L-Tyrosine PET in the clinical evaluation of brain tumors in childrenand adolescents.

Dunkl, V.
2015

Journal of Nuclear Medicine Journal of nuclear medicine, 56 56 (2014 2014) 1 1, S. 88-92 88-92

“...Langen, K.-J....”

17

Role of O-(2-18 F-Fluoroethyl)-L-Tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis

Galldiks, N.
2012

Journal of Nuclear Medicine Journal of nuclear medicine, 53 53 (2012 2012) 9 9, S. 1367-1374 1367-1374

“...Langen, K.J....”

18

Assessment of treatment response in patients with glioblastoma using [18F]Fluoroethyl-L-Tyrosine PET in comparison to MRI

Galldiks, N.
2012

Journal of Nuclear Medicine Journal of nuclear medicine, 53 53 (2012 2012) 7 7, S. 1048-1057 1048-1057

“...Langen, K.J....”

19